Quantcast
Last updated on April 17, 2014 at 9:54 EDT

Latest BRCA2 Stories

2014-04-04 12:23:54

These genes could explain why some women with high-risk mutations suffer from cancer while others do not Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. Spanish National Cancer Research Centre (CNIO) researchers are conducting a study that will contribute towards giving every woman far...

2014-03-26 23:25:49

Fulgent Diagnostics announces a clinical BRCA1/BRCA2 full gene sequencing test for $500. Temple City, California (PRWEB) March 26, 2014 In addition to the BRCA1/BRCA2 full gene sequencing test, Fulgent Diagnostics has also added a gene rearrangement test for an additional cost of $400. Fulgent Diagnostic's BRCA1/BRCA2 full gene sequencing test with rearrangement provides valuable information that can lead to potential treatment options that could mitigate certain risks. These options...

2014-03-19 23:04:03

A study published in last month’s Journal of Clinical Oncology suggests that women with the BRCA1 gene mutation may significantly reduce their chances of ovarian cancer if they have their ovaries removed by age 35. Abington, PA (PRWEB) March 19, 2014 Among study participants who underwent oophorectomy (ovary removal surgery), their chances of ovarian and breast cancers decreased by 80 percent. Additionally, their risk of death from any cause by age 70 decreased 77 percent as a result of...

2014-03-14 16:22:34

Large-Scale Sculpture Celebrates Hope for Patients and Families Carrying BRCA Mutations PHILADELPHIA, March 14, 2014 /PRNewswire/ -- On Wednesday, the University of Pennsylvania's Basser Research Center for BRCA formally unveiled "Homologous Hope," a new sculpture suspended from the glass atrium in the Perelman Center for Advanced Medicine. The large-scale piece was created especially for the Basser Research Center for BRCA by the New York-based internationally renowned artist Mara G....

2014-02-27 16:26:09

COMBINING SCIENCE AND ART, THE SCULPTURE ECHOES THE OPTIMISM SURROUNDING RECENT BREAKTHROUGHS IN BREAST CANCER RESEARCH NEW YORK, Feb. 27, 2014 /PRNewswire/ -- On March 12, 2014, the Basser Research Center for BRCA, at the Ruth and Raymond Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania, will unveil "Homologous Hope," a dramatic sculpture commissioned from internationally renowned artist Mara G. Haseltine. http://photos.prnewswire.com/prnvar/20140227/NY73843 An...

2014-01-24 13:26:27

In laboratory experiments conducted on human cell lines at the Johns Hopkins Kimmel Cancer Center, scientists have shown that people carrying certain mutations in two hereditary cancer genes, BRCA2 and PALB2, may have a higher than usual susceptibility to DNA damage caused by a byproduct of alcohol, called acetaldehyde. The scientists say they suspect that the two genes in their normal forms evolved to protect cells against the damaging effects of acetaldehyde, which can lead to cancer....

2014-01-11 23:01:48

The US Supreme court ruled recently that the test patent is no longer valid causing pricing for Genetic testing to plummet. Thousand Oaks, CA (PRWEB) January 11, 2014 BRCA gene is currently the most well known breast cancer (and ovarian cancer) gene. Women with a BRCA1 and/or BRCA2 gene mutation are up to eight times more likely to develop breast malignancy than women without. In other words, the lifetime risk for getting breast cancer is up to 85%. If and when cancer happens, it tends...

2013-12-09 12:25:53

Quest and Alamo Breast Cancer Foundation also Co-Hosting Panel on "Cancer and BRCA Testing in the News, the Arts and Popular Culture," Joined by Director of Upcoming Film "Decoding Annie Parker" MADISON, N.J., Dec. 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that BRCAvantage(TM), a service-rich oncology offering designed to increase access to BRCA testing for at-risk patients and maximize the value...

2013-11-27 15:48:08

Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Women with certain mutations in their BRCA1 or BRCA2 genes are at increased risk for breast cancer. However, if a woman who comes...

2013-10-28 12:26:27

NEW BRUNSWICK, N.J., Oct. 28, 2013 /PRNewswire-USNewswire/ -- Researchers from GeneAssess, Inc., a Foundation Venture Capital Group portfolio company, announce the publication of the genetic studies that led to the identification of the FRY gene as a breast cancer susceptibility suppressor gene. "We see great promise in Dr. Zarbl's discovery of the FRY gene and how it might be used to affect the diagnosis and treatment of aggressive breast cancers," noted James M. Golubieski, president of...